monitoring of blood coagulation and platelet function by using TEG6s during and after discontinuation of anti-platelet and new oral anticoagulant

monitoring of blood coagulation and platelet function by using TEG6s during and after discontinuation of anti-platelet and DOAC - monitoring of blood coagulation and platelet function by using TEG6s during and after discontinuation of anti-platelet and DOAC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037183

Enrollment

100

Registered

2019-06-27

Start date

2019-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients medicated anti-platelet and DOAC

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients scheduled to operation, and medicated and discontinued anti-platelet and DOAC

Exclusion criteria

Exclusion criteria: patients without cooperation or disagreed from patients family

Design outcomes

Primary

Measure	Time frame
The changes in characteristics of blood coagulation during and after discontinuation of DOAC The changes in platelet function during and after discontinuation of anti-platelet	—

Countries

Japan

Contacts

Public ContactKouji Hamaya

Sapporo Medical University School of Medicine Hospital section

ko-hamaya-923@sapmed.ac.jp011-611-2111

Outcome results